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Although the physiological regulatory function of the gasotransmitter NO (a diatomic free radical) was discovered decades
ago, NO is still in the frontline research in biomedicine. NO has been implicated in a variety of physiological and pathological
processes; therefore, pharmacological modulation of NO levels in various tissues may have significant therapeutic value. NO is
generated by NOS in most of cell types and by non-enzymatic reactions. Measurement of NO is technically difficult due to its
rapid chemical reactions with a wide range of molecules, such as, for example, free radicals, metals, thiols, etc. Therefore,
there are still several contradictory findings on the role of NO in different biological processes. In this review, we briefly
discuss the major techniques suitable for measurement of NO (electron paramagnetic resonance, electrochemistry,
fluorometry) and its derivatives in biological samples (nitrite/nitrate, NOS, cGMP, nitrosothiols) and discuss the advantages
and disadvantages of each method. We conclude that to obtain a meaningful insight into the role of NO and NO modulator
compounds in physiological or pathological processes, concomitant assessment of NO synthesis, NO content, as well as
molecular targets and reaction products of NO is recommended.
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Introduction
Although the physiological regulatory function of the gas-
otransmitter NO was discovered decades ago, NO is still in the
frontline research as shown by the continuously increasing
number of annual hits for ‘nitric oxide’ in the PubMed data-
base. The increasing interest in NO in biomedical research is
due to several facts: (i) NO is an ubiquitous free radial mol-
ecule found in most of cells of all tissues intracellularly as well
as in the extracellular fluids; (ii) NO is involved in a variety of
physiological and pathological processes; and (iii) utilization
of gaseous NO and some NO donor molecules for human
therapy has entered into clinical therapy and the develop-
ment of further NO-related therapies are promising (see for
review, Pacher et al., 2007). However, the chemical reactions
of NO with other free radicals and various small and macro-
molecules have raised many new questions regarding the
involvement of NO in different cellular or intercellular/
interorgan signalling pathways. Moreover, measurement of
NO is technically difficult, due to its rapid chemical reactions
with a wide range of biomolecules and its very short half-life
of approximately a few seconds. Therefore, there are still
contradictory findings on the role of NO in several biological
processes as reviewed previously by Ferdinandy and Schulz
(2003) and Schulz et al. (2004). Correct application of the
different NO measurement techniques are essential to gain
more knowledge on the physiology and pathology of NO.
In this review, we describe the major techniques used
most frequently in the literature for measurement of NO in
biological samples and discuss the advantages and disadvan-
tages of each method.
Synthesis and major metabolic
pathways of NO
NO is a diatomic hydrophobic gas that can permeate various
cellular membranes and other hydrophobic structures, and
thus it has a high diffusion capacity in a physiological envi-
ronment. NO can be produced in biological systems by both
enzymatic and non-enzymatic reactions. In mammals, NO
is biosynthesized endogenously by various isoforms of
NOS using the substrates L-arginine and molecular oxygen
(Figure 1). NOS catalyses the oxidation of the terminal guani-
dino nitrogen of L-arginine to produce NO and L-citrulline.
Several cofactors are required for the reaction including
NADPH, flavin adenine dinucleotide, flavin mononucleotide,
haem, tetrahydrobiopterin and calmodulin. Insufficient
availability of L-arginine and some of the cofactors (i.e.
tetrahydrobiopterin), as well as S-glutathionylation of
certain NOS isoforms may lead to reduced NO formation and
uncoupling of NOS resulting in superoxide production
(Forstermann and Li, 2011; Zweier et al., 2011). Three distinct
isoforms of NOS have been described in mammals: neuronal
NOS (nNOS, NOS-1), endothelial NOS (eNOS, NOS-3) and
inducible NOS (iNOS, NOS-2) (Knowles et al., 1989; Mayer
et al., 1989; Mulsch et al., 1989; Palacios et al., 1989; Palmer
and Moncada, 1989; Stuehr et al., 1989; Moncada et al., 1997;
Forstermann and Sessa, 2012). Moreover, the existence of a
putative mitochondrial NOS (mtNOS) has also been sug-
gested (Zaobornyj and Ghafourifar, 2012). The constitutively
expressed isoforms nNOS and eNOS are Ca2+-dependent,
whereas iNOS is Ca2+-independent (Moncada et al., 1991).
The biological effects of NO and the activities of NOS isoen-
zymes are further regulated by compartmentalization
(Villanueva and Giulivi, 2010) as well as transcriptional, post-
Figure 1
Major metabolic pathways of NO.
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transcriptional and post-translational modulations such as
for instance phosphorylation, S-nitrosation, interaction with
modulatory proteins (e.g. calmodulin, HSP90, caveolin, etc.),
dimerization, inhibition by endogenous methyl-arginines,
etc. (as reviewed in detail elsewhere, Zhou and Zhu, 2009;
Pautz et al., 2010; Qian and Fulton, 2013).
It has been clarified that NOS-independent reduction of
dietary or endogenous sources of nitrate and nitrite are
important contributors for the production of NO in mamma-
lian tissues (Lundberg et al., 2008; Rassaf et al., 2014)
(Figure 1). Nitrate found in significant amounts in certain
vegetables (e.g. lettuce, spinach and beetroot, etc.), needs to
be initially reduced to nitrite by nitrate reductase enzymes of
bacteria in the gastrointestinal tract. Nitrite – also found in
certain dietary sources – can be reduced to NO by several
pathways and conditions including low pH, ascorbic acid,
haemoglobin, myoglobin, polyphenols and xanthine oxi-
doreductase (Lundberg et al., 2008; Rassaf et al., 2014). The
formation of NO by these pathways may become especially
important during hypoxia when pH becomes acidic and
oxygen-dependent NOS activities are limited.
NO has a short biological half-life (estimated to be a few
seconds) due to its rapid reaction with a variety of molecules
(Figure 1). Although the chemistry of NO is well-established
in a test tube, the exact biochemistry of NO is still far from
clear (Hill et al., 2010). The biologically relevant reactions of
NO have been reviewed elsewhere in more detail (Gow, 2006;
Bryan and Grisham, 2007; Habib and Ali, 2011; Tennyson
and Lippard, 2011). The major pathway for the metabolism
of NO is its oxidation to nitrite and nitrate eventually fol-
lowed by their urinary excretion. NO in the presence of
molecular oxygen is oxidized to nitrogen-dioxide (NO2),
which by reacting with another NO molecule forms N2O3, an
intermedier that participates in nitrosation reactions. N2O3
may be decomposed to nitrite and a one-electron reduction
of NO2 may also lead to nitrite formation. Nitrite has a half-
life of a few minutes in the circulation as it can be further
oxidized to the more stable nitrate by certain oxyhaemopro-
teins such as oxygenated haemoglobin or myoglobin. Alter-
natively, NO may directly react with oxyhaemoproteins to
form nitrate (Bryan and Grisham, 2007). In addition to its
reaction with oxygen, NO rapidly reacts with superoxide to
yield peroxynitrite, a short-lived oxidant, nitrating and nitro-
sating agent (Pacher et al., 2007; Radi, 2013).
Important molecular targets of NO are transition metal
ions. NO binds to transition metal ions to form nitrosyl-metal
ion complexes. The nitrosyl-Fe2+ adduct – such as in haem – is
particularly stable, as the binding of the nitrosyl ligand to Fe2+
is very strong. Relevant examples of proteins in which the
formation of nitrosyl-metal complexes affect biological func-
tion include soluble GC (sGC, see later), haemoglobin, cyto-
chromes, etc (Toledo and Augusto, 2012). NO – following
oxidation to N2O3 – plays an important role in the formation
of S-nitrosothiols (RSNOs) via S-nitrosation of small molecu-
lar weight thiols and thiol-containing proteins (Broniowska
and Hogg, 2012). This type of reaction is often incorrectly
referred to as ‘S-nitrosylation’ (i.e. direct addition of NO to a
reactant) in the literature [for more details on NO chemistry
and terminology see a recent review by Heinrich et al.,
(2013)]. Nevertheless, NO may also react directly with thiyl
radicals formed after oxidation of thiols to produce RSNOs.
Enzyme-dependent and -independent S-nitrosation, transn-
itrosation and denitrosation are potential post-translational
modifications that may regulate biological function of several
proteins (Lima et al., 2010; Stamler and Hess, 2010; Gould
et al., 2013; Maron et al., 2013). RSNOs may play an impor-
tant role in endogenous transport and storage of NO as well
as in NO-related cell signalling.
Analytical tools for the assessment
of NO: what to consider
before selection?
In general, NO measurement techniques can be classified as
direct (the target of measurement is NO itself) and indirect
methods. Most of the NO measurement techniques in the
literature are indirect ones that are measurements of NOS
activities, activation of molecular targets of NO, such as
GC-derived cGMP, or products of reactions of NO, such as
RSNOs or nitrite/nitrate. The major analytical tools for the
detection of these analytes are spectroscopic or electrochemi-
cal methods. The spectroscopic methods include colorimetric,
fluorometry, luminometry and electron spin resonance spec-
troscopy (ESR). These analytical tools have been extensively
reviewed previously (Hetrick and Schoenfisch, 2009; Coneski
and Schoenfisch, 2012). The sensitivity and specificity of these
techniques for NO varies a lot, and they cannot provide an
insight into the in situ NO levels in biological systems. Direct
NO measurement techniques that are more specific for NO
such as, for example, ESR after in vivo or ex vivo spin trapping
or NO-specific biosensors are less frequently used.
Choosing the most appropriate method for measurement
of NO in biological systems is not easy. Therefore, we suggest
consideration of two additional aspects before planning
experiments. Firstly, for the measurement of NO, a variety of
different commercial products are available on the market,
most of which can be purchased in ready-to-use formats.
However, these kits and/or instruments that operate with
different background principles are developed for various sci-
entific, industrial and environmental application purposes.
Secondly, the specificity and cross-reactivity of the NO
sensors with NO derivatives (e.g. reactive nitrogen species
such as peroxynitrite) and other non-NO-related molecules
(e.g. reactive oxygen species) still remain a major challenge in
NO research (Rodriguez-Rodriguez and Simonsen, 2012;
Woolley et al., 2013). This is mainly due to the small size of
the NO molecule and its complex chemical nature in biologi-
cal systems. Therefore, before scientific use, careful consid-
eration of various aspects including background assay
principle, specificity, sensitivity, advantages, disadvantages
and financials (see Table 1) is strongly recommended to
choose the most proper analytical technique(s), which best
fits the study objectives. As an aid to finding the most appro-
priate method(s) for measurement of NO in a particular
study, a detailed questionnaire can be constructed and
answered as suggested by Wardman (2007). Moreover, we
suggest the use of NO donors for positive control and inhibi-
tors of NO formation as negative controls to complete the
data obtained either by direct or indirect assays to understand
the exact role of NO in biological systems.
BJP C Csonka et al.
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In the present review, we focus on the most important
possibilities to determine NO or its derivatives in biological
matrices. We discuss background assay principles, specifici-
ties, sensitivities, advantages/disadvantages and possible
limitations.
Direct methods to estimate NO
Electron paramagnetic resonance spectroscopy
As NO is a free radical, hence of paramagnetic nature, elec-
tron paramagnetic resonance spectroscopy (EPR; also referred
to as ESR) is considered to be the most appropriate tool for the
direct detection of NO. The main advantage of EPR compared
with other NO detection techniques is that it only detects
paramagnetic molecules, and the EPR spectrum is a unique
fingerprint of the chemical and electronic structure around
the unpaired electron. EPR measures the transitions induced
between the Zeeman levels of a paramagnetic molecule via its
interaction with a static magnetic field and an oscillating
electromagnetic field, most commonly in the X microwave
frequency band, around 9–9.5 GHz. To take an EPR spectrum,
the microwave frequency is held constant and the static mag-
netic field is swept (despite its name) across the desired range.
The equation for resonance absorption is ΔE = hv = gβB, in
which h is Planck’s constant; ν is the frequency of the micro-
waves; β is the Bohr magneton, a physical constant; B is the
external magnetic field; and g is the g-value, or the Zeeman
splitting factor (Weil and Bolton, 2007). The g-value is a
characteristics of the paramagnetic molecule [in case of NO in
liquid g = 2.035, (Hogg, 2010)]. A further specific property of
EPR spectra originates from the coupling of the electron spin
with the surrounding nuclear magnetic spins, measured by
the so-called hyperfine coupling constant, A, in mT.
The paramagnetic NO can be measured directly by EPR
irrespective of the optical appearance of the sample; however,
due to the rapid relaxation of its excited electron spin state to
the ground state (Maples et al., 1991) and the high reactivity
of NO, spin-trapping techniques have been developed. Spin
traps are compounds that interact with the less stable radi-
cals, producing a more stable adduct, which can be then
detected by EPR (Janzen, 1984; Tosaki et al., 1996; Berliner
and Fujii, 2004; Villamena and Zweier, 2004).
Table 1
Specificity and major advantages and disadvantages of techniques of NO assessment with a brief summary
Technique Sensitivity Advantages Disadvantages
EPR
NO spin trapping followed by
spectrometry in magnetic field
0.05–0.4 nMa Direct, considered as a ‘stand alone’
assay; the most specific method,
due to NO-specific spin traps
Semiquantitative; expensive, not particularly
common instrumentation; complex
evaluation requires significant expertise
Electrochemistry
amperometry or voltammetry
using NO-specific electrode
0.3–10 nMb Direct; continuous; real-time,
portable; no chemical
contamination of the sample
Difficult to calibrate; influenced by
temperature and ambient electrical noise;
uncertain specificity (NO-specific membrane
or layer); sensitive to electrode tip position
Fluorometry
spectrometry or imaging of
fluorophore-labelled NO
0.6–8 nMc Direct; sensitive (detection limit in
nM range); can be two- or
three-dimensional
Uncertain specificity (NO-specific fluorescent
dyes); semiquantitative
Griess assay
diazotization assay measures
nitrite by photometry
500 nMd Cheap, fast; commercially available
ready-to-use kits
Indirect, indicative of NO oxidative products;
only measures nitrite (nitrate should be
reduced); interferes with dietary and
environmental nitrite and nitrate
NOS activity
biochemical enzyme activity
assay
n.a. Measures enzymatic production of
NO; sensitive; specific
Indirect; non-enzymatic NO formation is not
considered; measures active NOS protein
under optimized in vitro conditions, does
not reflect in situ NO synthesis
RSNO
detection of nitrosated
proteins/peptides
n.a. Important NO target besides cGMP;
represents downstream NO
signalling
Indirect; represents downstream NO
signalling; does not reflect actual NO levels
cGMP assays
measurement of cGMP level
n.a. Most known cellular target of NO is
sGC resulting in cGMP formation;
represents downstream NO
signalling
Indirect, assesses effect of NO on sGC;
represents downstream NO signalling; does
not consider NO-independent cGMP
formation
NO donors and NOS
inhibitors
n.a. Use of them completes other assays;
helps to understand the role of NO
Alone does not reflect NO production
aMülsch et al., 1992; Khoo et al., 2004; Nedeianu et al., 2004.
bGriveau et al., 2013.
cZhang et al., 2014.
dSun et al., 2003. n.a., not applicable.
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As natural spin traps, the iron centre of haemoglobin and
other haem-proteins may interact with NO with high affinity
forming nitrosyl derivatives, which are paramagnetic and
exhibit a characteristic EPR spectrum (Greenberg et al., 1990;
Henry et al., 1991; Eriksson, 1994; Katayama et al., 2001). The
spectra of the haemoglobin-NO is sensitive to many factors
such as tertiary and quaternary structures of the protein,
concentration of O2, pH, degree of hydration, temperature,
etc. (Sanches, 1988; Hall and Buettner, 1996). The detection
limit of haemoglobin-NO has been reported to be ∼200 nM,
but the basal level of NO in blood appears to be below this
limit (Piknova et al., 2005).
There are several classes of chemical spin traps for the
detection of NO like the (i) nitroxide spin traps (Arroyo and
Forray, 1991a; Arroyo and Kohno, 1991b) including nitrones
(e.g. DMPO, 5,5-dimethyl-pyrroline-N-oxide and its related
spin trap, DEPMPO, 5-diethoxyphosphoryl-5-methyl-1-
pyrroline-N-oxide; PBN, α-phenyl-N-tert-butyl-nitrone; and
POBN, α(4-pyridyl-1-oxide)-N-tert-butyl-nitrone) and nitroso
compounds (e.g. MNP, 2-methyl-2-nitrosopropane and
DBNBs, 3,5-dibromo-4-nitrosobenzene); (ii) the NO cheletro-
pic traps (double carbon-centred biradical equivalents; Korth
et al., 1992); and (iii) the nitronyl nitroxides (e.g. carboxy-
PTIO, [2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-
1-oxide] (Katayama et al., 2001; Hawkins and Davies, 2014).
However, the spin traps mentioned earlier have several limi-
tations, such as instability at certain pH and low sensitivity or
selectivity (Katayama et al., 2001; Hawkins and Davies, 2014).
The efficiency of NO spin trapping can be sharply
increased using various transition metal complexes (see, e.g.
Archer, 1993; Henry et al., 1993). Thus, the most popular and
most extensively used NO spin traps are the iron (II) dithi-
ocarbamate (DTC) type of complexes (Kleschyov et al., 2007;
Hong et al., 2009; Hogg, 2010). Iron complexed with N,N-
diethyl-dithiocarmabate [DETC, (Mordvintcev et al., 1991;
Mülsch et al., 1992)] is hydrophobic, whereas iron com-
plexed with N-methyl-D-glucamine dithiocarmabate (MGD;
Komarov et al., 1993) is hydrophilic; hence, these iron com-
plexes trap NO in different environments. One of the major
advantages of using these iron complexes as spin traps is that
they react with NO extremely rapidly, that is NO binds to
dithiocarbamate complexes with a rate constant of 1–5 ×
108 M−1·s−1 (Hogg, 2010). Fe2+(DTC)2 are suitable spin traps for
NO in vivo and in real-time measurements because the rate
constant of the formation of NO-Fe2+(DTC)2 adduct is much
larger than that with other NO spin traps (Vanin et al., 2000;
Nagano and Yoshimura, 2002), and also because of the high
solubility of NO in membranes (Nedeianu et al., 2004).
Whereas DETC is soluble in aqueous media, it is ferrous
and the mononitrosyl ferrous complexes precipitate at
neutral pH (Csont et al., 2003). Therefore, when injected in
animals, it is recommended to inject Fe2+ separately from
DETC. The reagents are inexpensive, commercially available
and are typically used in vivo [100 mM DETC, 20 mM Fe(II),
usually at a ratio of 1 iron : 5 ligand (Berliner and Fujii,
2004)]. The Fe2+(DETC)2 is distributed throughout the body,
as observed by the detection of the NO-Fe2+(DETC)2 com-
plexes in different organs in vitro and in vivo in animal models
[see, e.g. Csont et al. (1998); Fejer et al. (2005); for a review,
see Hong et al. (2009)], while Fe2+(MGD)2 is suitable for ex vivo
spin trapping in different tissue samples and cell cultures
(Csonka et al., 1999; Radak et al., 1999; Csont et al., 2010),
including human tissue samples (Radak et al., 1999).
NO interacts with high affinity with these Fe2+(DTC)2
complexes forming stable nitrosyl iron-dithiocarbamate com-
plexes [according to Vanin et al. (2000) the predominant
binding of iron to dithiocarbamate ligands takes place only
after its binding to NO, as nitrosylated iron manifests much
higher affinity for these ligands that for any non-thiol com-
pounds (Vanin and Poltorakov, 2009)]. At ambient tempera-
ture, the solution of NO-Fe2+(DTC)2 is characterized by the
isotropic EPR signal at a g-value of 2.035 and triplet hyperfine
structure (not shown) and a spectrum with axial symmetry in
the frozen state (Figure 2A). The triplet (three-line) splitting
originates from the hyperfine interaction of an unpaired elec-
tron with the 14N nucleus of the NO ligand [solution spectra
are characterized in Nedeianu and Pali (2002)]. DETC pen-
g = 2.004
× 0.1
Figure 2
X-band EPR spectra of NO-Fe2+(DETC)2 complex in left ventricular
tissue samples of rat hearts. Trace A: dotted line, positive control (NO
donor sodium nitroprusside), with gain reduced by a factor of 10
compared with curves B–D; solid line, sum of Lorentzians fitted to the
NO signal. Trace B: background spectrum, Cu2+(DETC)2. Trace C:
negative control (NOS inhibitor NG-nitro-L-arginine). Trace D:
increased NO production in nitroglycerine-tolerant animals. The
solid lines on trace D are the fitted spectrum from trace A, but scaled
down to match the +1 and −1 hyperfine lines, upper and lower solid
lines, respectively, of the NO spectral component of the spectrum.
The +1, 0, −1 numbers indicate the hyperfine lines of
NO-Fe2+(DETC)2 triplet (perpendicular orientation). The +3/2, +1/2,
−1/2, −3/2 numbers indicate the hyperfine lines of Cu2+(DETC)2
(perpendicular orientation). Sample temperature was 160 K, central
field and scan range are 335.6 and 34.0 mT respectively. The g =
2.004 position of the g-value was determined using a g standard.
Figure was modified with permission from Csont et al. (1998).
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etrates the cell wall and binds not only the free intracellular
Fe2+, but also endogenous Cu2+ forming a Cu2+(DETC)2
complex, characterized by a four-line EPR spectrum that over-
laps with the NO-Fe2+(DTC)2 spectrum at low temperature
(Suzuki et al., 1997; see also Figure 2B).
Specimens in a quartz tube with a small sample volume
(<100 μL) are measurable in an X-band EPR spectrometer.
However, larger biological samples (e.g. tissues, organs and
live animals) cannot be measured with a conventional
X-band spectrometer due to the high dielectric loss of water
at such frequencies, and the small size of the EPR cavity
resonator. EPR spectroscopy at lower frequencies, the L-band
(0.4–1.6 GHz) or S-band (1.6–4 GHz), can be used for in vivo
EPR imaging (Nagano and Yoshimura, 2002; Fujii and
Berliner, 2004). As the NO-Fe2+(DTC)2 complexes are still reac-
tive free radicals, freezing of the samples until and during
measurement is required. Measurements are done typically
below 200 K. The detection limit of NO by the DTC-based
spin trapping EPR method is 0.05 nM in biological samples
(Mülsch et al., 1992; Khoo et al., 2004). We found the detec-
tion limit for NO released from an NO donor to be 0.4 nM in
solution under anaerobic conditions (Nedeianu et al., 2004).
However, precise and absolute quantification of EPR detec-
tion of NO in biological samples is not reliable due to an
uneven distribution of the spin trap complex Fe2+(DTC)2 in
the aqueous and the lipid phase of biological samples
(Ferdinandy et al., 1997). In addition, as the concentration of
the Fe2+(DTC)2 complexes cannot be predicted from the con-
centration of Fe2+ and DTC administered, and as the trapping
efficiency of the spin trap in the given environment is not
known, absolute quantitation of NO is not a realistic objec-
tive in practice. Hence, in the vast majority of studies, relative
changes in the NO level are reported as NO signal intensity in
arbitrary units.
Typical EPR spectra are shown in Figure 2 for NO trapped
with Fe2+(DETC)2 (traces A, C and D), together with the most
common compromising signal Cu2+(DETC)2 (trace B) and the
spectra of control samples. The EPR spectrum is proportional
with the first derivative of the microwave absorption (Y-axis,
measured in arbitrary units) as function of the magnetic field
(B, X-axis). The second integral of the EPR spectrum (the area
under the absorption spectrum) is proportional to the
number of spins present in the active volume of the resona-
tor. Therefore, in this case, the second integrals can be used
for relative quantitation of NO. In Csont et al. (1998) for
instance, analysis of NO content was performed with double
integration of all spectra, after subtracting the background
signal of Cu2+(DETC)2. However, in most studies, the back-
ground signal also changes significantly from sample to
sample, even if the same test tube is used for the sample and
the background signals. As the second integral approach is
very sensitive to the baseline, an alternative approach is fol-
lowed: the use of a positive control, which is the same tissue,
but loaded with an NO donor and the spin trap. A positive
control yields an NO triplet that has much higher intensity
than the background signal, hence, it can be analysed and
fitted easily [this technique was used in Fejer et al. (2005)]. A
fit of a simulated NO signal to the positive control is also
shown in Figure 2 trace A, solid line. A simple approach to
evaluate NO spectra is to measure the peak-to-peak amplitude
of the +1 and/or the −1 NO peak and compare them with that
of a positive control signal (Radak et al., 1999; Csont et al.,
2010).
In summary, EPR measurement of NO spin-trapped with
Fe2+(DTC)2 provides a very sensitive and one of the most
specific methods for direct detection of NO both in vivo and
in vitro. The EPR spectrum is characteristic for the nitrosyl-
adduct and it can be recorded under various conditions;
however, the limitation of this method is that complex evalu-
ation of the results requires significant expertise.
Electrochemical assays using microelectrodes
specific for NO
There are a lot of different electrochemical assays available for
NO measurement. They all integrate the advantages of elec-
trochemistry: small size, continuous (often in situ) and fast
measurements, no chemical contamination of the samples
(thus samples can be used for other assays). However, large
differences may occur among the different electrodes in selec-
tivity. Selectivity is controlled by the voltage applied between
the electrodes (∼860 mV) and the NO-selective layer around
or on the surface of the electrode.
The majority of electrodes on the market dedicated to
measure NO uses micro ion electrodes measuring simply
nitrite and/or nitrate. For the advantage and disadvantage of
nitrite and nitrate measurement versus direct NO measure-
ment, see succeeding sections. Compared with the classical
Griess spectrophotometric assay, which is the gold standard
of nitrite/nitrate determination, use of electrodes has several
advantages: (i) requires smaller amount of samples; (ii) wide
range of samples can be used including turbid, opaque or
even non-liquid samples for example cell cultures, tissues and
tissue homogenates; (iii) per sample cost savings over Griess;
(iv) avoid interferences during measurements from other
components for example NADPH and antioxidants; and (v)
minimize sample preparation steps.
To date, among the several electrochemical techniques
that have been shown to be useful for the direct measurement
of NO, amperometric detection of NO is the most popular
technique sensitive enough to detect relevant concentrations
of NO in real-time and in vivo (Serpe and Zhang, 2007; Davies
and Zhang, 2008; Yap et al., 2013). Generally, this technique
involves applying a fixed (poise) voltage potential to a
working electrode versus a reference electrode, and monitor-
ing the redox current produced by the oxidation of NO (Serpe
and Zhang, 2007). This technique has proven to be very
useful for NO detection due to its fast response time of less
than a few seconds, and its acceptable sensitivity. In amper-
ometry, both electrodes are encased within a protective
Faraday-shielded stainless steel sleeve. The tip of the sleeve is
covered with an NO-selective membrane, and the sleeve itself
contains electrolyte (Davies and Zhang, 2008). NO diffuses
across the gas-permeable/NO-selective membrane (e.g. nitro-
cellulose, chroloprene, silicon, Teflon, graphene, Nafion, cel-
lulose acetate and polycarbazole) and ultimately is oxidized
at the working electrode surface producing a redox current
(Serpe and Zhang, 2007; Wang and Hu, 2009). The selectivity
of the membranes for NO is still debatable, and after NO
diffuses through the membrane, there is no more qualitative
control on the analytical signal. The amount of NO oxidized
is proportional to the current flow between the working and
reference electrodes, which is measured by an NO meter. The
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redox current generated by the oxidation of NO in biological
systems is extremely small, typically in the range of 1–10 pA
corresponding to an approximately 10−8–10−9 M concentra-
tion range (Table 1).
In addition to amperometry, voltammetry techniques
may provide an alternative electrochemical approach to
detect NO; however, they are less frequently used. These
techniques typically employ a classical three-electrode con-
figuration consisting of a working electrode, reference elec-
trode and a counter electrode.
Besides the classic Clark-type electrodes mentioned
earlier, where selectivity is insured by a passive NO-selective
membrane or layer around the electrode, a new generation of
NO electrodes have been recently developed (Wang and Hu,
2009; Bedioui et al., 2010; Jiang et al., 2013; Yap et al., 2013).
Instead of membranes believed to ensure NO-selectivity, an
NO-specific active scavenger layer is electropolymerized onto
the surface of a glassy carbon electrode that can chemically
react directly with NO. Among these materials, the electropo-
lymerized film of metalloporphyrins has been used most
extensively (Diab et al., 2003; Li et al., 2009). Electric signals
form only after the direct chemical link between NO and the
electropolymerized layers of the electrode; thus, electrocata-
lytic oxidation of NO enhance NO specificity of the electrode
significantly. Parallel with advancements in nanotechnology
(e.g. Santos et al., 2013), recently there has been significant
progress in the development of these electrodes. Hence, they
have great potential as a future technology suitable for direct
NO measurements in biological samples.
Even if electrochemical techniques offer great promise for
the measurement of NO production, some disadvantages
should be considered. The tip of the electrode is used to
detect the signal; therefore, the location of the electrode is
critical as small changes in its position can dramatically influ-
ence spatial information. Theoretically, this problem can be
eliminated using ultramicroelectrode sensor arrays in which
each electrode, or groups of electrodes, are individually
addressable, and used for mapping the analyte to achieve
spatio–temporal analysis (Quinton et al., 2011; Griveau and
Bedioui, 2013). As NO dissolves well in lipids, the distance of
the electrode from different membranes may also influence
signal intensity. The diameter of the electrodes, which varies
from the micrometre to the millimetre range, also influences
the sensitivity of the electrode as the surface of the electrode
(determined by diameter and length) is proportional to the
NO signal detected. To get reliable results using electrochemi-
cal assays, the preparation of standard solutions to calibrate
the electrode is also a critical step in the measurement, and all
the following options are rather problematic: (i) application
of gaseous NO to prepare a standard solution (concentration
can be calculated from the dissolving coefficient, and deoxy-
genation of the standard is important to prevent oxidation of
NO); (ii) known concentration of NO donors; or (iii) NO
produced by chemical reactions (Serpe and Zhang, 2007).
Temperature may affect sensitivity of the electrode by influ-
encing the partial pressure of dissolved NO, the permeability
of the coatings and the conductivities of various sensor com-
ponents. Therefore, a careful temperature control is recom-
mended during calibration and experiments. External
electrical noise sources (e.g. magnetic stirrers, fluorescent
lights, MRI machines, electric motors, computers, pumps and
other electrical instruments) may couple into the sensor
signal path electromagnetically and impose undesirable
signals on the output record. Because NO signal intensity is in
the pA range, it is important to ground and shield the system
properly (Serpe and Zhang, 2007).
Fluorometry
Fluorescence assays are sensitive techniques for detection of
NO. The assay principle is that NO and/or its oxidative
derivatives react with a non-fluorescent compound forming
a fluorescent product. Fluorescent compounds (frequently
called probes or dyes) greatly vary in their specificity for NO
and applicability in biological systems. In order to detect the
spatial and temporal dimensions of NO generation and accu-
mulation in living cells, the fluorescent compounds must
pass several strict criteria. The probe should be small, cell or
membrane permeable, non-toxic, water soluble, photostable,
have excitation/emission wavelengths in the visible range
to minimize damage of biological samples, well-separated
excitation/emission wavelengths, possesses a large extinction
coefficient and quantum yield, and have a large signal-to-
noise ratio and linear response. In addition, it is highly desir-
able that the molecular probe is selective for NO among
competing reactive nitrogen species. If oxidized forms of NO
such as nitrite and nitrate, and also reactive oxygen species,
such as superoxide, hydrogen peroxide, and peroxynitrite,
do not react with the probes to give a fluorescent product,
then in the absence of NO fluorescent dye is not formed.
Once the fluorescent dye is formed, it can be detected by any
instrument suitable for detection of fluorescence, including
flow cytometers, microscopes, fluorescent microplate readers
and fluorometers. Fluorescence microscopy can provide two-
or even three-dimensional imaging, and high spatial–
temporal resolution; therefore, in biological samples, it is
the most informative detection technique despite limited
quantification.
There are two main classes of different fluorescent probes
specifically designed for NO measurement: organic-based and
metal-based sensors. In both instances, the goal is to alter the
fluorescent properties of the probe by specific reaction with
NO. Organic probes employ fluorophores with pendant func-
tional groups that serve to quench their fluorescence until
restored by a specific reaction with NO. Metal-based probes
take advantage of the high reactivity of NO with transition
metals to form metal-nitrosyl complexes (McQuade and
Lippard, 2010b).
The first fluorescent probe developed for the measure-
ment of NO was diaminonaphthalene (DAN) (Ji and
Hollocher, 1988). However, Ji and Hollocher (1988) suggested
that chemical nitrosation of DAN requires O2, therefore, DAN
directly measures oxidative derivatives of NO (N2O3). Later,
Misko et al. developed an assay using DAN to detect nitrite in
biological samples (Misko et al., 1993). Another popular
organic-based fluorescein probe, diaminofluorescein (DAF),
was developed more than 15 years ago (Kojima et al.,
1998a,b). DAF is essentially non-fluorescent until it reacts
with NO (or more precisely N2O3) to form a fluorescent ben-
zotriazole. Besides specificity, cell membrane permeability
was improved by developing its diacetate derivative, which
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passively diffuses across cellular membranes. Once inside
cells, it is deacetylated by intracellular esterases to become
membrane-impermeable. These probes have been extensively
used for estimation of NO production in a variety of biologi-
cal samples. However, it turned out that DAF-2 can be enzy-
matically converted into a variety of highly fluorescent
derivatives both intra- and extracellularly, of which only a
minor part appeared NO-dependent (Roychowdhury et al.,
2002). Thus, DAF-fluorescence does not necessarily indicate
NO·production; therefore, it is not generally accepted as an
NO-specific probe. The presence or absence of oxygen (i.e. in
ischaemia or reperfusion) can also influence fluorescence
through formation of N2O3 (Rumer et al., 2012). Despite these
limitations, further applications of DAF were developed, that
is a high-throughput technique based on DAF-fluorescence
capable of detecting RSNOs (Doctor et al., 2005). Other
frequently used organic NO fluorophores are o-
diaminorhodamines (DARs; typically DAR-2 and DAR-4M
AM), o-diamino-boron-dipyrromethenes (DAMBOs; typically
DAMBO and DAMBO-CO2Et), and o-phenylenediamine cya-
nines (DACs) (Nagano, 2009; Zhang et al., 2014). The cur-
rently used organic fluorescent probes are reviewed in
(Nagano, 2009; 2010; Woolley et al., 2013).
As organic probes are not suitable for direct detection of
NO, metal-based probes were also developed. As transition
metals can reversibly form bonds with NO, many researchers
have focused on metal–ligand constructs where the ligand
contains a fluorophore. (McQuade and Lippard, 2010a). To
date, NO sensing has been accomplished using a wide array of
metal ions, including Co(II), Fe(II), Ru(II), Rh(II) and Cu(II)
(Hong et al., 2009; Hu et al., 2011). One of the most promis-
ing of metal-based sensors for direct, cellular detection of NO
is a copper-based fluorescent probe CuFL (Lim et al., 2006;
McQuade and Lippard, 2010b).
Although, the use of fluorescent techniques is a pro-
mising tool to detect NO, it has several disadvantages. The
optimal dilution buffer and working concentration of the
fluorescent dye, and optimal loading concentration, time and
temperature are needed to be determined empirically, which
can vary among different labs. Moreover, quantification of
NO is nearly impossible. It is desirable to use the lowest dye
concentration yielding fluorescence signals with adequate
signal-to-noise ratios. Moreover, close excitation/emission
wavelengths, cytotoxicity, strong auto-fluorescence, small
extinction coefficient and insufficient solubility in neutral
buffers, pH dependence of the fluorescence intensity are
mentioned as further disadvantages of this method. Some
further limitations still exist to affect sensitive imaging of NO,
such as poor photostability (e.g. DAFs, DACs and transition
metal complex probes), small changes of fluorescence
quantum yield after reaction with NO (e.g. DACs and transi-
tion metal complex probes), fast leakage from cells (e.g. DAFs
and DARs) and possible fluorescence interference from bio-
logical matrix (e.g. DAFs, DAMBOs and DARs) (Zhang et al.,
2014).
A great deal of improvement has been made to fluorescent
NO probes in recent years, mostly in the area of sensitivity
and selectivity (e.g. Nagano, 2010; Rodriguez-Rodriguez and
Simonsen, 2012; Woolley et al., 2013; Alam et al., 2014;
Zhang et al., 2014). Although these improvements have
allowed for more accurate measurements of NO, the specific-
ity of fluorophores for NO is still a very important issue and
needs to be further validated in biological systems.
Indirect methods to estimate NO
Determination of nitrate/nitrite
Due to its short half-life, the direct measurement of NO is
extremely challenging in a complex biological environment.
As NO is rapidly metabolized to nitrite and nitrate in the
presence of oxygen (Figure 1), the determination of both
nitrite and nitrate (termed NOx) is commonly used to esti-
mate total NO production. A number of analytical techniques
have been developed to determine nitrite and nitrate in bio-
logical samples including the Griess colorimetric assay,
fluorometry, flow or sequential injection analysis with visible
absorbance, chemiluminescence and electrochemical detec-
tion (Moorcroft et al., 2001; Bryan and Grisham, 2007).
Chromatographic methods including GC–MS, capillary elec-
trophoresis, and HPLC have also been developed using a
variety of detection systems.
A major general disadvantage of nitrite/nitrate determi-
nation to estimate tissue NO level is that dietary intake of
nitrite (e.g. cured meat) and nitrate (e.g. vegetables) are rather
significant, which markedly influences plasma NOx level
(Rassaf et al., 2014). In addition, environmental conditions
such as nitrite/nitrate pollution in chemical reagents, cell
culture media, and even plastic labware may interfere with
nitrite/nitrate analysis.
Nitrite and nitrate can be measured from a variety of
biological fluids. A relatively simple, long-known colorimet-
ric assay based on the Griess reaction is probably used most
extensively for assaying NOx. The Griess reaction – also called
diazotization assay – is based on the conversion of nitrite to
a purple-coloured azo-dye that can be spectrophotometrically
assayed at a wavelength of ∼540 nm. The most widely used
reagents required for the reaction are sulphanilamide and
N-naphthyl-ethylenediamine (Moorcroft et al., 2001; Sun
et al., 2003; Bryan and Grisham, 2007; Hetrick and
Schoenfisch, 2009). Advantages of this method include a
strong literature background, numerous commercially avail-
able reagent kits and wide availability of infrastructure.
However, prior to this reaction, nitrate needs to be reduced
either chemically or enzymatically to nitrite in order to deter-
mine NOx. Chemical reduction is not specific for the nitrate–
nitrite conversion and nitrite may be reduced further to NO
thereby leading to underestimation of nitrite (Sun et al.,
2003). Enzymatic reduction of nitrate by nitrate reductase
requires NADPH; however, excess NADPH interferes with the
subsequent Griess reaction and thus limits sensitivity of the
assay. Moreover, the high protein content of cell lysates and
plasma may interfere with the nitrate reduction or the Griess
reaction; therefore, deproteinization of samples is highly rec-
ommended. As the detection limit is ∼0.5 μM of nitrite/
nitrate, this assay is not suitable for measuring physiological
amounts of NO (Sun et al., 2003; Hetrick and Schoenfisch,
2009).
The other most widely used approach for the analysis of
nitrite and nitrate is based on electrochemical detection. For
general advantages and disadvantages of the electrochemical
approach, see previous sections.
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Estimation of NO formation by measuring
NOS activity
Measurement of NOS activity may provide an alternative
solution for investigating NO metabolism both in vivo and in
vitro (Figure 1). NOS activity can be determined by measuring
either L-citrulline or the NO metabolites nitrite/nitrate. The
classical citrulline assay is based on the conversion of 3H- or
14C-labelled L-arginine to L-citrulline, where after removal of
unreacted L-arginine with resin, radioactivity of the end-
product L-citrulline is proportional to NOS activity. Radioac-
tivity is usually measured by liquid scintillation counting.
This method is suitable for distinguishing Ca2+-dependent
and Ca2+-independent NOS activities. It is relatively sensitive
(Hevel and Marletta, 1994) and after improvement by
Giraldez and Zweier (1998) it became suitable for detection of
low levels of NOS activity found in certain tissues (e.g. heart).
NOS enzyme activity measured in vitro conditions
strongly depends on the availability of exogenously admin-
istered cofactors such as tetrahydrobiopterin (also known as
sapropterin) and NADPH. A radiochemical HPLC-based cit-
rulline assay was developed for the measurement of NOS
activity in intact tissue samples (de Bono et al., 2007; Crabtree
et al., 2009a,b), thereby avoiding the influence of the meas-
urements by exogenously administered cofactors.
Other commonly used assays for measurement of NOS
activity are based on detection of nitrite/nitrate generated
from NO. These assays are less specific, but more simple and
cost effective compared with the citrulline assay, and are also
suitable for high-throughput analysis. Another method to
improve specificity and sensitivity of NOS activity assays
based on nitrate/nitrite determination involves a GC–MS
based measurement of 15N-labelled nitrite/nitrate converted
from L-[guanidino-15N]-arginine-derived 15NO (Tsikas, 2008;
Shin and Fung, 2011).
NOS activity assays indicate the amount of enzymatically
active NOS protein in a biological system under optimized in
vitro conditions; however, they do not necessarily reflect in
vivo NO production and actual NO concentration. Care
should be taken to avoid interference by other enzymes
affecting L-arginine metabolism (e.g. arginase) and non-
enzymatic NO formation should be also considered. Specific-
ity of the assays should be ensured by application of
inhibitors of NOS isoforms in parallel measurements.
Detection of RSNOs in biological systems
Protein RSNOs derived from NO and/or its derivatives
(Figure 1) play an important role in NO signalling in both
physiological and pathological conditions. Therefore, measure-
ment of RSNOs contributes to the understanding of NO bio-
chemistry; however, it does not directly reflect actual NO levels.
To date, no universal direct method exists to identify
protein RSNOs specifically. The most commonly used
methods for the detection of S-nitrosated proteins are (i)
Saville reaction (simplest and least expensive) in which
mercury replaces a nitrosyl from a thiol group to form nitrite
followed by Griess assay (Saville, 1958); (ii) biotin switch
(suitable to detect low μM concentrations of biotinylated
proteins without requiring special instrumentation)
(Jaffrey and Snyder, 2001; Forrester et al., 2009); and (iii)
chemiluminesence-based assays (Basu et al., 2008). A DAF-
fluorescence-based high-throughput technique measuring
RSNOs in the low nanomolar range was also described
(Doctor et al., 2005). Mass spectrometry detection became the
gold standard for directly studying low-level RSNOs in a
physiologically relevant context (Barglow et al., 2011);
however, it is expensive and requires 15N-labelled internal
standards (Gow et al., 2007). The methods mentioned earlier
suffer from lengthy preparative protocols and selectivity
issues. Most recently, triarylphosphines and cyclization reac-
tions with phosphines have been addressed to be the mile-
stones of direct detection of RSNOs; however, these methods
require further improvements (Bechtold and King, 2012).
Estimation of NO formation by
measuring cGMP
In biological systems, the most known target of NO is sGC that
is responsible for the synthesis of cGMP (Figure 1). The con-
nection between NO and cGMP in most of the tissues is so
close that cGMP is frequently used as a surrogate for the rate of
NO synthesis both in vitro and in vivo (Tsikas, 2008); however,
the relationship between tissue NO and cGMP level in the
heart tissue seems more complicated (Csont et al., 1998).
There are several available methods to measure cGMP in a
variety of biological samples including tissue lysate, blood,
urine and culture supernatants. RIAs are commercially avail-
able, with high specificity and sensitivity (pM range) (Steiner
et al., 1972; Evgenov et al., 2004). The method is based on the
competitive binding of cGMP in the sample and a radioiodi-
nated derivative of cGMP ([125I] cGMP) to a highly specific
antibody. After separation of antibody-bound cGMP from
free cGMP, 125I is determined by a γ-counter.
A similar immune-detection approach applying non-
radioactive reagents is used in commercially available ELISA
assays with colorimetric detection of optical densities by a
plate reader. Another method for cGMP quantification is
liquid chromatography coupled to tandem mass spectrom-
etry (LC-MS) characterized by complicated sample prepara-
tion and high sensitivity and selectivity (Lorenzetti et al.,
2007; Martens-Lobenhoffer et al., 2010).
All these methods mentioned earlier are expensive and
labour intensive. Moreover, these are end point assays, not
suitable for real-time measurements. However, real-time
monitoring of cGMP based on homogenous time-resolved
fluorescence has been recently described (van Mastbergen
et al., 2012). In addition, NO reporter assays were also devel-
oped allowing real-time detection of NO synthesis within
living cells (Wunder et al., 2005; 2007).
Although determination of cGMP is frequently used to
demonstrate NO production in biological systems, cGMP level
is modified by several other factors including activities of par-
ticulate GC and phosphodiesterases, sampling time, subcellular
localization and NO-independent regulation of sGC (Lucas
et al., 2000; Bender and Beavo, 2006; Francis et al., 2010).
Conclusions
A wide range of analytical methods are available for the
detection of NO in biological samples; however, each method
has certain advantages and limitations. Therefore, the use of
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direct NO detection methods as first choice should be consid-
ered. In addition, a series of methods to follow NO synthesis,
NO content, molecular targets and reaction products of NO are
recommended to get meaningful insights into the role of NO
in a certain physiological or pathological process. Moreover,
application of NO donors and NOS inhibitors to provide
appropriate positive and negative controls is also recom-
mended to overcome limitations of individual methodologies.
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